Biohaven Ltd
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
BHVN$15.23+5.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(Amounts in thousands, except share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $248,402 | $204,877 |
| Marketable securities | 133,417 | 260,464 |
| Prepaid expenses | 35,242 | 20,945 |
| Income tax receivable | 13,252 | 46,139 |
| Restricted cash held on behalf of Former Parent | — | 35,212 |
| Other current assets | 12,133 | 19,331 |
| Total current assets | 442,446 | 586,968 |
| Property and equipment, net | 17,191 | 17,512 |
| Intangible assets | 18,400 | 18,400 |
| Goodwill | 1,390 | 1,390 |
| Other non-current assets | 33,785 | 37,513 |
| Total assets | $513,212 | $661,783 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $15,577 | $10,703 |
| Due to Former Parent | — | 35,212 |
| Accrued expenses and other current liabilities | 39,846 | 44,106 |
| Total current liabilities | 55,423 | 90,021 |
| Long-term operating lease liability | 27,569 | 30,581 |
| Other non-current liabilities | 2,245 | 2,410 |
| Total liabilities | 85,237 | 123,012 |
| Commitments and contingencies (Note 12) | ||
| Shareholders' Equity: | ||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2023 and 2022 | — | — |
| Common shares, no par value; 200,000,000 shares authorized as of December 31, 2023 and 2022; 81,115,723 and 68,190,479 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 887,528 | 615,742 |
| Additional paid-in capital | 39,804 | 13,869 |
| Accumulated deficit | (499,292) | (91,124) |
| Accumulated other comprehensive (loss) income | (65) | 284 |
| Total shareholders' equity | 427,975 | 538,771 |
| Total liabilities and shareholders' equity | $513,212 | $661,783 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.